With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

Illumina currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader medical space are IDEXX ...

Centralized migration accelerates adaptation and drives parallel evolution, emphasizing the key influence of spatial organization on evolutionary dynamics across systems from pathogen transmission to ...

The DNA Diagnostics Market is poised for growth due to increasing chronic and infectious diseases. Opportunities lie in next-generation sequencing advancements and oncology diagnostics, driven by ...

Dublin, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The "Canada Next-Generation Sequencing (NGS) Market - A Canada and Regional Analysis: Focus on Application, Technology, Offering, End User, and Regional ...

In his Nobel Prize acceptance speech in 1980, genomics pioneer Fred Sanger described science as “a voyage of discovery into ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led ...

A research team has uncovered and reconstructed the complete biosynthetic pathway of polyphyllin II—a potent anticancer ...

Making is Fueling Strong Growth in Pan-Genomic and Multi-Gene Panel Testing, Supported by Expanding NGS Access, Advanced Bioinformatics Interpretation, and Wider Hospital ImplementationSan Francisco, ...

Researchers from the Faculty of Engineering at The University of Hong Kong (HKU) have developed two innovative deep-learning ...

Jan 13 (Reuters) - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help ...